Kent Edward Kester MD
HIV/AIDS Medicine, Healthcare Associated Infections, International Health, Travel & Tropical
Vice President and Head of Translational Medicine, IAVI
Join to view full profile
78 Swiftwater AvenuePocono Manor, PA 18349
Dr. Kester is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumFellowship, Infectious Disease, 1992 - 1995
University of MarylandResidency, Internal Medicine, 1986 - 1989
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1986
Certifications & Licensure
MD State Medical License 1987 - 2028
PA State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
National Board of Physicians and Surgeons Infectious Disease- National Board of Physicians and Surgeons Internal Medicine
Clinical Trials
Publications & Presentations
PubMed
- 60 citationsControlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing ColonizationHans de Graaf, Muktar Ibrahim, Alison R Hill, Diane Gbesemete, Andrew T M Vaughan
Clinical Infectious Diseases. 2020-07-11 - The promise of mRNA vaccines: a biotech and industrial perspective.Nicholas A C Jackson, Kent E Kester, Danilo Casimiro, Sanjay Gurunathan, Frank DeRosa
NPJ Vaccines. 2020-01-01 - 26 citationsCharacterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium.January Weiner, David J. M. Lewis, Jeroen Maertzdorf, Hans-Joachim Mollenkopf, Caroline L. Bodinham
Scientific Reports. 2019-12-30
Press Mentions
University of Oxford Launches World’s First Phase II Nipah Virus Vaccine TrialDecember 9th, 2025- Oxford’s Nipah Virus Vaccine Wins EMA PRIME Status in UK FirstJune 12th, 2025
- Chronic Lyme Infection-Associated Illness in Urgent Need of Symptom-Targeted TreatmentsJune 10th, 2025
Committees
- Member, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria 2015 - 2023
- Member, Vaccine and Related Biologics Advisory Committee, FDA 2011 - 2014
Professional Memberships
- Fellow
- Fellow
- American Society of Tropical Medicine & HygieneFellow
- Member
- Fellow
Industry Relationships
- Vice President and Head, Translational Science and Biomarkers, Sanofi Pasteur2015 - Present
- Associate VP and Head, Clinical and Translational Sciences, Sanofi Pasteur2014 - 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
